Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis
Adv Ther
.
2021 Aug;38(8):4598.
doi: 10.1007/s12325-021-01837-0.
Authors
Juanzhi Fang
1
,
Stephanie Korrer
2
,
Jonathan C Johnson
2
,
Mark A Cheadle
3
,
Roshani Shah
3
,
Matias L Ferraris
4
,
Cristina Lopez-Lopez
4
Affiliations
1
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. jenny.fang@novartis.com.
2
Optum, Eden Prairie, MN, USA.
3
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
4
Novartis Pharma AG, Basel, Switzerland.
PMID:
34273094
DOI:
10.1007/s12325-021-01837-0
No abstract available
Publication types
Published Erratum